Introduction
============

Enteric septicemia of channel catfish (ESC) is one of the most prevalent diseases of cultured catfish, causing significant losses ([@B38]). The most common practice in ESC treatment is use of feed medicated with oxytetracycline, sulfadimethoxine, or florfenicol. However, one of the earliest clinical signs of ESC is reduced appetite. Thus, these antimicrobials are only useful in limiting the spread of an outbreak and rather than treating the disease. Also, medicated feed may lead to the emergence of resistant *Edwardsiella ictaluri* strains ([@B37]).

The universal stress proteins (USP) have a conserved domain of 140--160 amino acids, and are present in archaea, bacteria, and plants ([@B29]), but not in animals and human ([@B34]). In *Escherichia coli usp* are involved in various functions from oxidative stress to adhesion and motility ([@B29]). Under stress, USPs are overproduced and through a variety of mechanisms aid the survival of organism in stressful conditions ([@B14]). The *uspA* mutation caused decreased survival in *E. coli* ([@B35]). It is known that USPs are needed by pathogens ([@B15]). USPs affect persistence and survival of *Mycobacterium tuberculosis* ([@B17]), and cause growth arrest and reduce the virulence in *Salmonella typhimurium* C5 ([@B25]) and *Burkholderia pseudomallei* ([@B4]). USPs are also necessary for the intracellular growth adaption of *Listeria monocytogenes* ([@B6]). Similarly, *Staphylococcus aureus* virulence factors were downregulated *in vivo* while expression of *uspA* increased ([@B5]). *Acinetobacter baumannii uspA* is essential in pneumonia and pathogenesis ([@B10]).

Although increased expression of several *usp* genes in *E. ictaluri* under various stressors has been reported ([@B2]), the role of USPs in *E. ictaluri* virulence is not known yet. Therefore, in this study, 10 *E. ictaluri usp* genes were studied by introducing in-frame deletions and determining their survival under acidic and oxidative stress conditions. Also, the virulence and protective properties of mutants against ESC infection were tested in catfish fingerlings.

Materials and Methods {#s1}
=====================

Animals
-------

All fish experiments were performed based on a protocol approved by the Mississippi State University Institutional Animal Care and Use Committee (protocol number 15-043). Channel catfish fingerlings were obtained from the fish hatchery at the College of Veterinary Medicine, Mississippi State University, and maintained at 25--28°C during experiments. Tricaine methanesulfonate (MS-222, Western, Chemical, Inc.) was used to sedate (100 mg/ml) or euthanize (400 mg/ml) the catfish.

Bacterial Strains, Plasmids, and Growth Conditions
--------------------------------------------------

Bacterial strains and plasmids used in this work are listed in Table [1](#T1){ref-type="table"}. *E. ictaluri* 93--146 wild-type (WT) was grown at 30°C using Brain Heart Infusion (BHI) broth and agar (Difco, Sparks, MD, United States). *E. coli* strains were cultured at 37°C using Luria-Bertani (LB) broth and agar (Difco). *E. coli* CC118λ*pir* was used for cloning and SM10λ*pir* or BW19851 were used for transferring pMEG-375 or pAK*gfplux*1 into *E. ictaluri.* When required, the following antibiotics and reagents (Sigma-Aldrich, Saint Louis, MN, United States) were added to culture medium at the following concentrations: ampicillin (Amp: 100 μg/ml), colistin (Col: 12.5 μg/ml), sucrose (5%), and mannitol (0.35%).

###### 

Bacterial strains and plasmids used in this study.

  Strain                        Relevant characteristics                                                                                       Reference
  ----------------------------- -------------------------------------------------------------------------------------------------------------- ------------
  ***Edwardsiella ictaluri***                                                                                                                  
  93--146                       Wild type; pEI1+; pEI2+; Col^r^                                                                                [@B24]
  *Ei*Δ*usp02*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp02*                                                               This study
  *Ei*Δ*usp03*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp03*                                                               This study
  *Ei*Δ*usp04*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp04*                                                               This study
  *Ei*Δ*usp05*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp05*                                                               This study
  *Ei*Δ*usp06*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp06*                                                               This study
  *Ei*Δ*usp07*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp07*                                                               This study
  *Ei*Δ*usp08*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp08*                                                               This study
  *Ei*Δ*usp09*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp09*                                                               This study
  *Ei*Δ*usp10*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp10*                                                               This study
  *Ei*Δ*usp13*                  93--146 derivative; pEI1+; pEI2+; Colr; Δ*usp13*                                                               This study
  ***Escherichia coli***                                                                                                                       
  CC118λ*pir*                   D(ara-leu); *araD*; DlacX74; *galE*; *galK*; *phoA20*; *thi-1*; *rpsE*; *rpoB*; *argE*(Am); *recAl*; lpirR6K   [@B16]
  SM10λ*pir*                    *thi; thr; leu; tonA; lacY; supE; recA*;::RP4-2-Tc::Mu; Km^r^; lpirR6K                                         [@B27]
  BW19851λ*pir*                 RP4-2 (Km::Tn7, Tc::Mu-1), DuidA3::pir+, recA1, endA1, thi-1, hsdR17, creC510                                  [@B26]
  **Plasmids**                                                                                                                                 
  pMEG-375                      8142 bp, Amp^r^, Cm^r^, lacZ, R6K ori, *mob incP, sacR sacB*                                                   [@B9]
  pAK*gfplux*1                  5681 bp, PstI, EcoRI, HpaI, AseI, BstBI                                                                        [@B22]
  p*Ei*Δ*usp02*                 9939 bp, Δ*usp02*, pMEG-375                                                                                    This study
  p*Ei*Δ*usp03*                 9960 bp, Δ*usp03*, pMEG-375                                                                                    This study
  p*Ei*Δ*usp04*                 10096 bp, Δ*usp04*, pMEG-375                                                                                   This study
  p*Ei*Δ*usp05*                 10080 bp, Δ*usp05*, pMEG-375                                                                                   This study
  p*Ei*Δ*usp06*                 10101 bp, Δ*usp06*, pMEG-375                                                                                   This study
  p*Ei*Δ*usp07*                 10026 bp, Δ*usp07*, pMEG-375                                                                                   This study
  p*Ei*Δ*usp08*                 10087 bp, Δ*usp08*, pMEG-375                                                                                   This study
  p*Ei*Δ*usp09*                 9843 bp, Δ*usp09*, pMEG-375                                                                                    This study
  p*Ei*Δ*usp10*                 9795 bp, Δ*usp10*, pMEG-375                                                                                    This study
  p*Ei*Δ*usp13*                 9975 bp, Δ*usp13*, pMEG-375                                                                                    This study

Construction of In-Frame Deletion Mutants
-----------------------------------------

The nucleotide sequences of 10 *E. ictaluri usp* genes were obtained from the *E. ictaluri* 93--146 genome (GenBank accession: CP001600), and four primers were designed for each gene (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). Restriction sites were included in forward and reverse primers. Overlap extension PCR was used to delete the functional *usp* genes from the *E. ictaluri* genome ([@B18]). Genomic DNA was isolated from *E. ictaluri* using a DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA, United States) and used as template in PCR. The upstream and downstream regions of each gene were amplified, and products were gel-extracted using a QIAquick Gel Extraction Kit (Qiagen). The amplified upstream and downstream fragments were mixed equally and used as a template in the subsequent overlap extension PCR to generate the in-frame deletion fragment for each gene. The in-frame deletion fragments were digested with appropriate restriction enzymes (NEB) (Table [2](#T2){ref-type="table"}) and cleaned up. The suicide plasmid pMEG-375 was purified from an overnight *E. coli* culture by a QIAprep Spin Miniprep Kit (Qiagen) and digested with appropriate restriction enzymes respective to the inserts. The in-frame deletion fragments were ligated into the linearized pMEG-375 vector using T4 DNA Ligase (NEB) at 16°C overnight. *E. coli* CC118λ*pir* was transformed by electroporation and plated on LB agar plus ampicillin. Resulting plasmids were isolated from the colonies and confirmed by size, restriction enzyme digestion, and finally by sequencing. The resulting plasmids named as p*Ei*Δ*usp02*-*10* and p*Ei*Δ*usp13* were transferred into *E. coli* SM10λ*pir* or BW19851 by chemical transformation and mobilized into *E. ictaluri* WT by conjugation. First integration was selected by ampicillin, and ampicillin resistant colonies were propagated on BHI agar to allow for the second crossover allelic exchange. After this step, colonies were streaked on counter selective BHI plates with 5% sucrose, 0.35% mannitol, and colistin to allow loss of pMEG-375. Potential mutant colonies were tested for ampicillin sensitivity to ensure the loss of the plasmid, confirmed by PCR, and sequencing.

###### 

The primers used for mutant construction and sequence validation.

  Genes       Primer ID        Primer Sequence (5′-3′)                             RE
  ----------- ------------ --- --------------------------------------------------- ---------
  *Eiusp*02   EI1751EF01   A   cccc**tctaga**agtgcggattgcattaca                    *Xba*I
              EI1751IR01   B   gaggtcgatggaaaccag                                  
              EI1751IF01   C   [ctggtttccatcgacctc]{.ul}gtactggtcgtccgctgatc       
              EI1751ER01   D   cccc**ggatcc**gattaacaacggcaaagtgg                  *BamH*I
              1751F            acctgtgccatttccgctgcc                               
  *Eiusp*03   EI1786EF01   A   cccc**gcggccgc**ttttcgtcgcgatagacttc                *Not*I
              EI1786IR01   B   gacgggaaccaaaatcgtc                                 
              EI1786IF01   C   [gacgattttggttcccgtc]{.ul}accaccagcgtcttggtagtg     
              EI1786ER01   D   cccc**gagctc**cagctgctccatgaaattacg                 *Sac*I
              1786F            gtatggcggtgataacatcc                                
  *Eiusp*04   EI1962EF01   A   cccc**gcggccg**cggaaaaacgtgtcattcgtc                *Not*I
              EI1962IR01   B   gttttggttcggatcgatag                                
              EI1962IF01   C   [ctatcgatccgaaccaaaac]{.ul}gaagatgagcatgatgac       
              EI1962ER01   D   cccc**gcatgc**catctctttcctgctgatgc                  *Sph*I
              1962F            tgatttgttgctcgtcggta                                
  *Eiusp*05   EI1981EF01   A   cccc**gcggccg**cggatcatatagcccatgctg                *Not*I
              EI1981IR01   B   ggatccggttttaagatcaag                               
              EI1981IF01   C   [cttgatcttaaaaccggatcc]{.ul}gacaccattagcattgatacg   
              EI1981ER01   D   cccc**gagctc**gaaatcctgacagccacttctg                *Sac*I
              1981F            ttaccatggcgcatttaggc                                
  *Eiusp*06   EI2616EF01   A   cccc**gcggccg**cattgtgacggaggagagatg                *Not*I
              EI2616IR01   B   cagaaccagaacatggtg                                  
              EI2616IF01   C   [caccatgttctggttctg]{.ul}gaccttgagaccgacgttctgg     
              EI2616ER01   D   cccc**gagctc**tgggaaatggtaaaacatgg                  *Sac*I
              2616F            atatccgtcgccgtcatacc                                
  *Eiusp*07   EI2891EF01   A   cccc**gcggccg**cgcgctgatcatcgtcttactg               *Not*I
              EI2891IR01   B   ctgtgccagcagggtgtc                                  
              EI2891IF01   C   [gacaccctgctggcacag]{.ul}gaaaccgataaggagatgacagac   
              EI2891ER01   D   cccc**gcatgc**gatacaggagcagggagttctgg               *Sph*I
              2891F            cgtcgaggctctgattacca                                
  *Eiusp*08   EI3729EF01   A   cccc**gcggccg**ctctccgacctgtaacaatcc                *Not*I
              EI3729IR01   B   cggagaaaggtctacagcaac                               
              EI3729IF01   C   [gttgctgtagacctttctccg]{.ul}catatcgacatgctgatcgtc   
              EI3729ER01   D   cccc**gagctc**agcagcttgccatagttcag                  *Sac*I
              3729F            gcgtttacaactgactccgg                                
  *Eiusp*09   EI3778EF01   A   cccc**gcggccg**caatcggtgtagaaggtgtcg                *Not*I
              EI3778IR01   B   ctcttcaatatcgacaggtac                               
              EI3778IF01   C   [gtacctgtcgatattgaagag]{.ul}aagaccaatgtgctggtg      
              EI3778ER01   D   cccc**gagctc**agaatcagggaggagtccag                  *Sac*I
              3778F            acaatctccggactctgtgg                                
  *Eiusp*10   Ei1634EF01   A   at**cccggg**tatttgctacccctacagtgcc                  *Xma*I
              Ei1634IR01   B   cagatcgaggagtgtactcat                               
              Ei1634IF01   C   [atgagtacactcctcgatctg]{.ul}gatcagccgacacaaagcctc   
              Ei1634ER01   D   at**gcatgc**cgacggtgttggatgagagct                   *Sph*I
              1634F            ccaccgaacacactagcaata                               
  *Eiusp*13   Ei3810EF01   A   at**cccggg**agcatcagtaccaccatcag                    *Xma*I
              Ei3810IR01   B   ggtcagggttgcagtcttatg                               
              Ei3810IF01   C   [cataagactgcaaccctgacc]{.ul}cagttaaacgcacgctatcag   
              Ei3810ER01   D   at**tctaga**cggacaatgcggatgatctga                   *Xba*I
              3810F            tcagctgtgtgggtagactg                                

Primers A, B, C, and D were used for mutant construction. Bold letters show restriction enzymes added to A and D primers. Underlined letters in primer C indicate reverse complemented primer B sequence. The last primer in each group used for sequence confirmation.

###### 

Summary of *E. ictaluri usp* genes and in-frame deletion.

  Gene      Locus ID      Gene ID   ORF size (bp)   Remaining US ORF (bp)   Remaining DS ORF (bp)   Deleted ORF (bp)/(%)
  --------- ------------- --------- --------------- ----------------------- ----------------------- ----------------------
  *usp02*   NT01EI_1751   *uspF*    435             15                      0                       420/(97)
  *usp03*   NT01EI_1786   --        432             8                       6                       418/(97)
  *usp04*   NT01EI_1962   *uspE*    960             28                      6                       926/(96)
  *usp05*   NT01EI_1981   *uspA*    417             24                      21                      372/(89)
  *usp06*   NT01EI_2616   *uspA*    420             12                      14                      394/(94)
  *usp07*   NT01EI_2891   *kdpD*    2709            30                      9                       2670/(99)
  *usp08*   NT01EI_3729   *uspA*    438             12                      27                      399/(91)
  *usp09*   NT01EI_3778   *uspA*    429             18                      12                      399/(93)
  *usp10*   NT01EI_1634   --        258             0                       9                       249/(97)
  *usp13*   NT01EI_3810   *cpxP*    480             3                       63                      415/(86)

US, Upstream; DS, Downstream; ORF, Open reading frame.

Construction of Bioluminescent USP Mutants
------------------------------------------

The constructed USP mutants were made bioluminescence using pAK*gfplux*1 plasmid as described previously ([@B21]). Briefly, the overnight culture of both recipient (USP mutants) and donor cells (*E. coli* SM10λ*pir* carrying pAK*gfplux*1) were mixed at 1:2 ratio (donor : recipient) and centrifuged briefly. Pellet was transferred onto sterile 0.45 μM filter papers placed on a BHI agar and incubated at 30°C for 24 h. Bacteria on the filter paper were collected in BHI broth with ampicillin and colistin and then spread on BHI plates containing ampicillin and colistin. After incubation at 30°C for 24--48 h, ampicillin resistant bioluminescent *E. ictaluri* colonies carrying pAK*gfplux*1 appeared on plates.

Growth Kinetics of the *E. ictaluri* USP Mutants in BHI
-------------------------------------------------------

Growth kinetics of the ten *E. ictaluri* USP mutants was compared to *E. ictaluri* WT in BHI medium as previously described ([@B1]). Each bacterial strain had four replicates. Overnight cultures were grown in a shaking incubator at 30°C for 18 h. The optical densities (OD~600~) were measured, and adjusted volumes were added to 15 ml fresh BHI (1:100 dilution). Cultures were grown for 24 h by sampling and measuring OD~600~ values at 2, 4, 8, 12, and 20 h.

Survival of *E. ictaluri* USP Mutants in Low pH Stress
------------------------------------------------------

Survival of bioluminescent USP mutants and *Ei*WT was determined under acidic stress (pH 5.5) as previously described ([@B33]). Bacteria were cultured overnight, and OD~600~ values were used to adjust culture volumes. The experiment was performed in 96 well black plates with four replicates at acidic and neutral pH. For each well, 5 μl of bacteria were inoculated into 195 μl of BHI broth plus ampicillin and colistin. The plates were incubated in Cytation 5 Cell Imaging Multi-Mode Reader (BioTek, Winooski, VT, United States), and the photon emissions were collected for 3 h at 30°C. Bioluminescence imaging (BLI) of the 96-well plate was taken using IVIS 100 Series (Caliper Corporation, Hopkinton, MA, United States). Three independent experiments were done and used for statistical analysis.

Survival of *E. ictaluri* USP Mutants in Oxidative Stress
---------------------------------------------------------

The survival of the ten USP mutants in BHI supplemented with 0.1% of H~2~O~2~ were determined as previously described ([@B33]). The experiment was performed in 96 well plates with four replicates under oxidative stress and normal conditions. The plates were incubated in Cytation 5 Cell Imaging Multi-Mode Reader, and the photon emissions were collected for 3 h at 30°C.

Virulence and Efficacy of *E. ictaluri* USP Mutants in Catfish Fingerlings
--------------------------------------------------------------------------

Virulence and vaccine efficacy trials were conducted as reported by our group ([@B20]). Approximately 720 channel catfish fingerlings (average: 13.728 cm, 10.544 g) were stocked into 36 tanks at a rate of 20 fish/tank. Tanks were divided into twelve groups with three replicate tanks each group. The experiment included 10 *E. ictaluri* USP mutants, positive control (*Ei*WT), and negative control (BHI exposed). After 1 week of acclimation, fish were challenged/vaccinated by immersion with 1.3 × 10^7^ CFU/ml water for 1 h. Mortalities were recorded daily for 21 days, and the mean percent mortalities were calculated for each treatment group. Protective properties of USP mutants against *Ei*WT infection was determined by challenging vaccinated catfish with *Ei*WT (2.8 × 10^7^ CFU/ml water). Fish mortalities were recorded daily, and the percent mortality was calculated for each group.

Statistical Analysis
--------------------

For the growth kinetic experiment, significant differences between *Ei*WT and USP mutants were determined by Student's *t*-test. For acid and hydrogen peroxide assays, photon counts were log~10~ transformed *t*-tests were conducted. Percent reduction in bioluminescence was calculated by dividing mean photon emissions of USPs to mean photon emission of *Ei*WT. For fish experiments, percent mortalities were arcsine transformed, and analysis of variance (ANOVA) was carried out using PROC GLM of SAS v9.4 (SAS Institute, Inc., Cary, NC, United States). In virulence/vaccination trial, the percent mortalities of USP mutants were compared to that of *Ei*WT, while in efficacy trail, the comparisons were made to the sham-vaccinated group at the alpha level of 0.05.

Results
=======

Construction of the *E. ictaluri* USP Mutants
---------------------------------------------

Thirteen universal stress proteins were identified in the *E. ictaluri* genome ([@B40]) by sequence similarity (Figure [1](#F1){ref-type="fig"}). They were scattered through the chromosome, and no operon structure was observed. We were able to delete 10 *E. ictaluri usp* genes in-frame, and mutants were verified by PCR (Figure [2](#F2){ref-type="fig"}) as well as sequencing. Properties of wild-type and mutated *usp* genes are shown in Table [3](#T3){ref-type="table"}. In-frame deletion resulted in removal of a large portion (86--99%) of the wild-type *usp* genes (Table [3](#T3){ref-type="table"}).

![Locations of studied universal stress proteins in *Edwardsiella ictaluri* strain 93--146 genome.](fmicb-09-02931-g001){#F1}

![Confirmation of *E. ictaluri* USP mutants by using forward (A) and reverse (D) primers. Fragments were amplified from mutant and wild-type strains and separated on two different 1% agarose gels, which were then combined (white lines above indicate joints). A 1 Kb+ marker lane was also added to the end. Lane 1, *Ei*WT (*usp02*) and lane 2, *Ei*Δ*usp02*; lane 3, *Ei*WT (*usp03*) and lane 4, *Ei*Δ*usp03*; lane 5, *Ei*WT (*usp*04) and lane 6, *Ei*Δ*usp04*; lane 7 is *Ei*WT (*usp05*) and lane 8, *Ei*Δ*usp05*; lane 9 is *Ei*WT *(usp06)* and lane 10 *is Ei*Δ*usp06*; lane 11 is *Ei*WT (*usp07*) and lane 12 is *Ei*Δ*usp07*; lane 13 is *Ei*WT (*usp08*) and lane 14 is *Ei*Δ*usp08*; lane 15 is *Ei*WT (*usp09*) and lane 16 is *Ei*Δ*usp0*9; lane 17 is *Ei*WT *(usp10)* and lane 18 is *Ei*Δ*usp10*; lane 19 is *Ei*WT (*usp13*) and lane 20 *is Ei*Δ*usp13*.](fmicb-09-02931-g002){#F2}

Growth Kinetics of the *E. ictaluri* USP Mutants in BHI
-------------------------------------------------------

The growth of *Ei*WT and USP mutants in BHI broth indicated that *Ei*Δ*usp03* and *Ei*Δ*usp04* have a significantly (*p* \< 0.001) higher growth rate than *Ei*WT. After 20 h incubation, the growth of *Ei*WT was 23.6 and 17.42% lower than *Ei*Δ*usp03* and *Ei*Δ*usp04*, respectively (Figure [3](#F3){ref-type="fig"}). Whereas, no significant differences were observed in the growth kinetics of *Ei*WT and *Ei*Δ*usp02*, *Ei*Δ*usp05*, *Ei*Δ*usp06*, *Ei*Δ*usp07, Ei*Δ*usp08, Ei*Δ*usp09, Ei*Δ*usp10*, and *Ei*Δ*usp13* strains at all tested time points.

![Growth of *E. ictaluri* USP mutants and WT in BHI broth. The data represent means of four replicates. *Ei*Δ*usp03* and *Ei*Δ*usp04* have a significantly (*p* \< 0.001) higher growth rate than *Ei*WT and other USP mutants, which indicated by a "^∗^." No significant differences were observed in the growth kinetics of *Ei*WT and *Ei*Δ*usp02*, *Ei*Δ*usp05*, *Ei*Δ*usp0*6, *Ei*Δ*usp07*, *E*iΔ*usp08*, *Ei*Δ*usp09*, *Ei*Δ*usp10*, and *Ei*Δ*usp13* strains.](fmicb-09-02931-g003){#F3}

Survival of *E. ictaluri* USP Mutants in Low pH Stress
------------------------------------------------------

To evaluate the role of *usp* genes in survival and growth of *E. ictaluri* at low pH, mutants and *Ei*WT were exposed to acidic pH (5.5) and neutral pH, and bacterial growth (quantified by bioluminescent signal) were calculated. The growth rate (photon numbers) of the all USP mutants in low pH was significantly lower than that of in neutral pH. In contrast, the growth of *Ei*WT at low pH was lower but not significant (Figures [4A,B](#F4){ref-type="fig"}). The strongest effect of low pH was observed in *Ei*Δ*usp03* growth (62% reduction) compared to *Ei*WT. The order of susceptibility of USP mutants in low pH as follows: Δ*usp*03 \> Δ*usp07* \> Δ*usp13* \> Δ*usp09* \> Δ*usp10* \> Δ*usp08* \> Δ*usp06* \> Δ*usp04* \> Δ*usp05* \> Δ*usp02*. The reduced growth of the USP mutants indicates that *usp* genes contribute *E. ictaluri* survival under acidic conditions.

![The survival assay of *E. ictaluri* WT and USP mutants in pH 5.5. **(A)** Each strain had four replicates (column A--D). Strains start with *E. ictaluri WT*, *Ei*Δ*usp02-13* and BHI control. **(B)** The bars show the difference between bioluminescence of USP mutants and WT. ^∗^indicates a significant difference between stress and non-stress at *P* \< 0.01.](fmicb-09-02931-g004){#F4}

Survival of *E. ictaluri* USP Mutants in Oxidative Stress
---------------------------------------------------------

Exposure to hydrogen peroxide (0.1% H~2~O~2~) significantly reduced growth of *Ei*Δ*usp05* and *Ei*Δ*usp08* compared to no stress group (91 and 35% reduction, respectively), while growth of *Ei*Δ*usp02* and *Ei*Δ*usp03* increased under oxidative stress (Figures [5A,B](#F5){ref-type="fig"}). No differences for *Ei*Δ*usp04*, *Ei*Δ*usp06*, *Ei*Δ*usp07*, *Ei*Δ*usp09, Ei*Δ*usp10*, and *Ei*Δ*usp13* strains were observed.

![The survival assay of *E. ictaluri* WT and USP mutants exposed to 0.1% H~2~O~2~. **(A)** Each strain had four replicates (column A--D). Strains start with *E. ictaluri WT*, *Ei*Δ*usp02-13* and BHI control. **(B)** The bars show the difference between bioluminescence of USP mutants and WT. **^∗^**indicates a significant difference between stress and non-stress at *P* \< 0.01.](fmicb-09-02931-g005){#F5}

Virulence and Efficacy of *E. ictaluri* USP Mutants in Catfish Fingerlings
--------------------------------------------------------------------------

The percent mortalities in catfish challenged with *Ei*Δ*usp05, Ei*Δ*usp07*, *Ei*Δ*usp08*, *Ei*Δ*usp09*, *Ei*Δ*usp10*, and *Ei*Δ*usp13* were significantly lower than that of *Ei*WT (20, 44.8, 20, 20, 55, and 10% vs. 74.1% mortality, respectively) (Figure [6A](#F6){ref-type="fig"}). In contrast, no significant differences between *Ei*Δ*usp02, Ei*Δ*usp03, Ei*Δ*usp04*, and *Ei*Δ*usp06* and *Ei*WT (79.8, 84.4, 74.6, and 79.82% vs. 74.1% mortality, respectively) were observed (Figure [6A](#F6){ref-type="fig"}). The order of attenuation in the 10 USP mutants are as following: *Ei*Δ*usp13* \> *Ei*Δ*usp05* \> *Ei*Δ*usp08* \> *Ei*Δ*usp09* \> *Ei*Δ*usp07* \> *Ei*Δ*usp10* \> *Ei*Δ*usp04* \> *Ei*Δ*usp06* \> *Ei*Δ*usp02* \> *Ei*Δ*usp03*.

![Vaccination tests of USP mutants in channel catfish fingerlings. **(A)** Percent mortalities seen after vaccination. **(B)** Percent mortalities of channel catfish fingerlings immunized with USP mutants and re-challenged with *E. ictaluri* wild-type 3 weeks post immunization. **^∗^**indicates significant differences between mutant and WT at *P* \< 0.01.](fmicb-09-02931-g006){#F6}

At 3 weeks post-immunization, *Ei*Δ*usp05, Ei*Δ*usp07*, *Ei*Δ*usp08*, *Ei*Δ*usp09*, *Ei*Δ*usp10*, and *Ei*Δ*usp13* provided significant protection against *Ei*WT challenges (no mortalities; *p* \< 0.01) compared to sham-vaccinated fish (58.33% mortality) (Figure [6B](#F6){ref-type="fig"}). Although immunization with *Ei*Δ*usp03* and *Ei*Δ*usp04* protected catfish significantly, they were not safe. *Ei*Δ*usp05, Ei*Δ*usp08*, *Ei*Δ*usp09*, and *Ei*Δ*usp13* were both safe and protective among all USP mutants.

Figure [7](#F7){ref-type="fig"} provides overall summary of the results.

![Overall summary of results. Survival percent under acidic (pH) and oxidative stress (H~2~O~2~) conditions was calculated based on changes in bioluminescence signal. The downward direction arrow indicates reduction in survival percent between mutant strain compared with wild type. The upward direction indicates increase in survival percent. Virulence percent is based on catfish mortality after immersion challenge with USP mutant strains. Efficacy perecent is based of mortality after re-challenge the immunized fish with *E. ictaluri* WT at 21 day post-immunization.](fmicb-09-02931-g007){#F7}

Discussion
==========

Several previous studies reported that universal stress proteins (USPs) play a role in different bacteria to respond to different stress conditions, such as heat, substrate starvation, exposure to antimicrobial agents, acidic stress, and oxidative stress ([@B33]). The objective of this study was to determine the role of *E. ictaluri usp* genes in acidic and oxidative stresses as well as in virulence. Also, mutants' vaccine potentials were determined.

The *uspA* gene among *usp* genes has been studied in different bacterial strains. Deletion of the *uspA* genes resulted in decreased virulence in *Salmonella typhimurium* C5*, Listeria monocytogenes*, and *Acinetobacter baumannii* ([@B25]; [@B33]; [@B10]). Also, *uspA* affected the host invasion and survival in *Salmonella enterica* and *Mycobacterium tuberculosis* ([@B15]; [@B17]). In the present study, there were four *usp* genes (*usp05*, *usp06*, *usp08*, and *usp09*) with high similarity to *uspA*. The growth rate of *Ei*Δ*usp05, Ei*Δ*usp06, Ei*Δ*usp08*, and *Ei*Δ*usp09* were similar to *E. ictaluri* WT. However, *Ei*Δ*usp05* and *Ei*Δ*usp08* showed reduced growth in oxidative and acidic stresses compared to *Ei*WT. Virulence data showed that *Ei*Δ*usp05, Ei*Δ*usp08*, and *Ei*Δ*usp09* were significantly attenuated compared to *E. ictaluri* WT. However, *Ei*Δ*usp06* was not attenuated. These results are consistent with a previous study in *L. monocytogenes* where not all *uspA* are involved in reduced virulence ([@B33]). Previously, our group reported that transposon insertion mutants in *usp05* reduced *E. ictaluri* virulence in catfish and provided better protection against ESC ([@B19]). Additionally, expressions of *usp05* were very high in response to host stress or high level of H~2~O~2~ in *E. ictaluri* ([@B2]). The *usp05* gene (*uspA)* is an important regulator of survival and virulence in many pathogens ([@B35]). In *E. coli*, *uspA* mutant caused a survival defect under a variety of growth-arrested conditions, whereas overexpression induced growth in the growth-arrested state. Our data suggest that *usp05, usp08*, and *usp09* are important virulence genes in *E. ictaluri*.

We demonstrated that *Ei*Δ*usp03* and *Ei*Δ*usp04* have a faster growth rate than *Ei*WT and other USP mutants. However, lack of *usp* genes did not cause growth differences in *Listeria monocytogenes* ([@B33]), *E. coli* ([@B30]) or other bacteria when cultured in conventional media ([@B25]; [@B17]). Indeed, *Ei*Δ*usp03* and *Ei*Δ*usp04* did not show any virulence attenuation in *E. ictaluri*, which was similar to USP mutant Rv2623 in *Mycobacterium tuberculosis* ([@B17]). This study suggested that *usp* genes might play a role in latency and persistence of chronic TB infection. We think that *usp*03 and *usp*04 are not involved in virulence but may play other roles in stress responses in *E. ictaluri*.

*Edwardsiella ictaluri* can survive and continue growth in up to 3 mM of H~2~O~2~ and low acidic pH 5.5. When the USP mutants and *Ei*WT exposed to low pH, growth rates did not change significantly. As shown previously, *L. monocytogenes* ATP Binding USPs exhibited role in the response to acid stress during exponential growth phase ([@B36]).

Our results indicated that *E. ictaluri usp07* contributes to virulence of *E. ictaluri*. Mortality was significantly decreased in the *Ei*Δ*usp07* mutant compared to *Ei*WT strain. The *usp*07 is a *KdpD* protein, and it contains a *uspA* domain ([@B13]). We included whole *KdpD* as *usp*07 because USP domain is located between the *N*-terminal sensor domain and *C*-terminal catalytic domain of this Osmo-sensitive K^+^ channel histidine kinase. Mutant *KdpD* in *Salmonella typhimurium* is attenuated in animal infection model and macrophage survival experiments. It also promotes resistance to osmotic, oxidative and antimicrobial stresses ([@B3]). *KdpD* is also involved in oxidative-osmotic stress, response to host, and virulence ([@B11]). In our gene expression study after host stress, *usp07* showed a very high expression level ([@B2]). It is important to note that *usp07* involved in *E. ictaluri* virulence and acid stress response.

The *usp*13 was described as a universal stress protein and extra cytoplasmic adaptor protein (*CpxP*) like protein ([@B40]). The *usp13* (*CpxP*) is placed in the inner membrane with histidine kinase *CpxA* and *CpxR*, a response regulator ([@B39]; [@B7]). *CpxP* is the most highly inducible member of the *Cpx* regulon, and it has elevated expression in response to both envelope stress and entry into stationary phase growth ([@B28]; [@B8]). The CPX system is important and required for virulence in both Gram-negative and -positive bacteria ([@B32]). Previously, we determined that *E. ictaluri*, *usp13* is highly expressed when exposed low acidic pH (5.5) and the catfish invasion ([@B2]). The *usp13* (*cpxP*) is an essential regulator of cell membrane stress in bacteria during host infection. Therefore, it is involved in the virulence of *E. ictaluri* with a very high reduction in virulence (Figure [6](#F6){ref-type="fig"}).

The expression of *E. coli usp* genes is controlled by some effector proteins and signaling molecules, such as SOS repose proteins ([@B12]; [@B23]; [@B31]). However, mechanisms of USPs in other bacterial species are not known entirely. Overall our results are in line with studies from various species that USPs were crucial for protecting the cells from the damaging effects of reactive oxygen species (ROS) ([@B29]; [@B25]; [@B33]; [@B10]; Figure [7](#F7){ref-type="fig"}).

Conclusion
==========

Our lab aims to develop live attenuated vaccines to protect catfish against *E. ictaluri* infections. Live attenuated bacterial should be both safe and confer full protection against wild-type infections. This study identified that *Ei*Δ*usp05*, *Ei*Δ*usp08, Ei*Δ*usp09*, and *Ei*Δ*usp13* strains have vaccine potential and further efforts, such as constructing double mutants to improve their safety, could be pursued. The data presented in this study display that USPs are essential for both stress physiology and pathogenesis in *E. ictaluri*.
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